This week, Hong Kong capital market witnessed many positive developments. Within just one week, four companies successfully listed on the Hong Kong Stock Exchange. Frost & Sullivan, our exclusive industry advisor, extends warm congratulations.Shougang Langze (2553.HK),Dajin Heavy Industry (1081.HK),Tianchen Biology (1779.HK),Longfeng Group (2290.HK)Successfully listed on the Hong Kong Stock Exchange!
All four companies chose Frost & Sullivan as their trusted partner to provide exclusive industry advisory services. We value and appreciate the choice and trust of our clients, and will continue to provide professional services to help more companies achieve higher-quality development in the capital market!
Frost & Sullivan has always been a leader in assisting companies with listings in Hong Kong. According toLiveReportBig Data (statistical data as of March 31, 2026), over the past 36 months and 12 months, and from January to March 2026, Frost & Sullivan provided listing industry advisory services for 195, 101, and 30 IPOs on the Hong Kong stock market respectively, ranking first in terms of number of services. We have extensive industry experience and communication skills with regulatory authorities, exchanges, investment institutions, and related organizations.
Recommended Reading
4 companies list on the Hong Kong stock market this week, with Frost & Sullivan serving 3!
6 companies list on the Hong Kong stock market this week, with Frost & Sullivan serving 5!
4 companies list on the Hong Kong stock market this week, with Frost & Sullivan fully involved!
Beijing Shougang Langze Technology Co., Ltd. (stock code: 2553.HK)
Beijing Shougang Langze Technology Co., Ltd.On June 3, it successfully listed on the main board of the Hong Kong capital market. The company is a leading enterprise in the carbon capture, utilization, and storage industry (also known as CCUS industry) in China. It aims to produce low-carbon products such as ethanol and microbial protein through carbon capture and utilization technologies, and provides low-carbon comprehensive solutions.
Dajin Heavy Industry Co., Ltd. (stock code: 1081.HK)
Dajin Heavy Industry Co., Ltd.On June 5, it successfully listed on the main board of the Hong Kong capital market. The company is a global leading provider of offshore wind power core equipment. With nearly 20 years of experience in the wind power industry, it offers "build + transport + delivery" one-stop solutions for large-scale offshore wind developers worldwide.
Tianchen Biopharmaceutical (Suzhou) Co., Ltd. (stock code: 1779.HK)
Tianchen Biopharmaceutical (Suzhou) Co., Ltd.On June 5, it successfully listed on the main board of the Hong Kong capital market. The company is a clinical-stage biopharmaceutical company focused on innovative biologics for allergic diseases and autoimmune diseases. It has developed differentiated product pipelines around anti-IgE antibodies and dual-functional antibody fusion proteins. The core product LP-003 is a next-generation anti-IgE antibody, and the key product LP-005 is a dual-functional antibody fusion protein targeting C5 and C3b complement. The company has established differentiated product pipelines for conditions such as allergic rhinitis, chronic spontaneous urticaria, allergic asthma, paroxysmal nocturnal hemoglobinuria, andcomplement-mediated kidney diseaseetc., and continues to advance innovation in autoimmune diseases through high-affinity antibody discovery platforms and dual-functional antibody development platforms.
Longfeng Group Holdings Limited (stock code: 2290.HK)
Longfeng Group Holdings LimitedOn June 5, it successfully listed on the main board of the Hong Kong capital market. The company is a leading pharmaceutical and health retail enterprise in Hong Kong, focusing on retail sales of three core categories: medicines, health products, and beauty skincare. Its products cover 11 categories including traditional Chinese medicine, Western medicine, dietary supplements, skincare products, cosmetics, MATERNAL AND INFANT products, and household daily items. It has 31 chain stores across Hong Kong, and also builds a full-channel retail system through online platforms, with a global supply chain network in Japan, Korea, Europe, and the United States.
During a company’s listing process in Hong Kong, Frost & Sullivan primarily undertakes the following tasks: helping issuers accurately and objectively understand their position in the target market, using objective market data to identify, support, and highlight the issuer’s competitive advantages, assisting the issuer, investment banks, and other intermediaries in writing important sections of the prospectus (such as overview, competitive advantages and strategy, industry overview, business, etc.), helping the issuer communicate with the exchange and investors, and assisting the issuer in responding to various questions regarding the industry by the exchange.
Since the Frost & Sullivan team began providing investment and financing advisory services to corporate leaders and management teams, it has helped nearly three thousand companies successfully list in Hong Kong and overseas. It is a leading company in the field of investment and financing strategic consulting in China. Frost & Sullivan has long collaborated closely with globally renowned investment banks, accounting firms, law firms, investment institutions, and leading enterprises in the industry, establishing an efficient domestic platform for connecting investment and financing needs, enabling rapid formation of comprehensive consulting teams. Over the past 10 years, Frost & Sullivan has consistently held the leading position in the market share of professional industry advisors for Chinese companies listing in Hong Kong and overseas. In recent years, Frost & Sullivan reports have also been widely used in the prospectuses of leading A-share and Sci-Tech Innovation Board listed companies, as well as in research reports for primary and secondary markets and other capital market documents.
